Background Systemic immune‐inflammation index (SII) is a novel inflammatory marker
based on neutrophils, platelets and lymphocytes counts, which has potential prognostic …

Background Chronic low-grade inflammation is the common mechanism of both
atherosclerosis and type 2 diabetes mellitus (T2DM), and systemic immune-inflammation …

Background. Inflammation has been considered to play an important role in the
pathogenesis of the thoracic ossification of the ligamentum flavum (OLF). However, the …

Objective Deep vein thrombosis (DVT) progressing to pulmonary embolism is an important
cause of mortality and morbidity worldwide. At present, color Doppler ultrasound is the most …

The systemic immune-inflammation index (SII) has been developed for the risk
prognostication of acute coronary syndrome (ACS) patients. This meta-analysis aimed to …

The Global Registry of Acute Coronary Events (GRACE) score and the systemic immune-
inflammation index (SII) were used independently to predict adverse outcomes in patients …

Objective: Acute myocardial infarction constitutes one of the leading reasons for cardiac
mortality. Therefore, early identification of high-risk patients provides better prognostic …

Background The prognosis of ST-segment elevation myocardial infarction (STEMI) is closely
linked to left ventricular ejection fraction (LVEF). In contrast to primary percutaneous …

Background: In order to reduce the risk of leakage of cytotoxic agents, peripherally inserted
central catheters (PICC) are widely used in patients diagnosed with malignancy before …

This study aimed to evaluate the utility of the systemic immune-inflammation index (SII) in
predicting the development of Cardiac Implantable Electronic Device (CIED) infections. A …